Executive Director, V&I Outcomes Research Oncology, Precision Medicine and Portfolio RWE

This role leads real-world evidence generation that spans the oncology portfolio to inform market decisions for our company's oncology medicines and diagnostics/biomarkers. It supports tumor, asset, and precision medicine value evidence strategy, and demonstrates value in real-world settings. Under the guidance of a senior leader, this position leads a team of outcomes research professionals to develop value evidence strategies and generate real-world evidence that informs market decisions related to oncology medicines and associated diagnostics and biomarkers.

Responsibilities

• Leads, manages, and provides scientific and strategic direction to teams developing and executing high-quality evidence strategies and plans.
• Leads development and execution of Precision Medicine Outcomes Research plans that inform market decisions and span cross-tumor and asset needs.
• Ensures Outcomes Research plans deliver real-world evidence addressing cross-tumor/asset needs, including data quality assessment, federated data network development, and adaptable protocols with V&I stakeholders to advance patient care and identify unmet data needs/gaps.
• Develops strong matrix relationships with clinical development, medical affairs, tumor and asset Outcomes Research, market access, biomarker, companion diagnostic, precision medicine commercial, and key markets to ensure real-world evidence informs market decisions.
• Represents team perspectives to shape the strategy and function of the outcomes research organization through involvement in the extended leadership team and leading strategic initiatives.
• Partners with internal stakeholders and external thought leaders in precision medicine and real-world evidence to maintain awareness of the external environment and inform value evidence strategies.
• Stays aware of new scientific and methodological developments in Oncology and encourages application of new methods to real-world evidence, including precision medicine studies.
• Ensures study conduct aligns with company policies, SOPs, and worldwide regulations, including Good Pharmacoepidemiology Practice (GPP).
• Accountable for innovative and effective dissemination of value evidence deliverables through scientific congresses, peer-reviewed journals, press releases, promotional materials, and social media.

Requirements

• Doctoral degree (PhD, MD, DrPH, ScD) in a relevant discipline (health services research, outcomes research, epidemiology, public health, health economics, pharmacoeconomics, pharmacy administration).
• Ten or more years of experience post-degree.
• Track record of successful team leadership and global experience in real-world evidence.
• Demonstrated knowledge and evidence generation supporting optimal recommendations/guidelines, reimbursement, and payer/provider access and treatment decisions.

Preferred Qualifications

• Strong published research in Precision Medicine Oncology and Real-World Evidence.

Skills

• Required: Biomarkers, Cross-Functional Leadership, Evidence Generation, Executive Leadership, Oncology, Outcomes Research, Precision Medicine (PM), Real World Evidence (RWE), Scientific Leadership, Scientific Publications, Stakeholder Relationship Management.
• Preferred: Experience with federated data networks, adaptable protocols, and precision medicine evidence generation.

Pay

The salary range for this role is $255,800.00 - $402,700.00. An employee’s position within the salary range will be based on factors including relevant education, qualifications, certifications, experience, skills, geographic location, and business needs. The successful candidate will be eligible for annual bonus and long-term incentive, if applicable.

Benefits

• Medical, dental, vision, and other insurance benefits (for employee and family).
• Retirement benefits, including 401(k).
• Paid holidays, vacation, compassionate, and sick days.

Schedule

• Travel Requirements: 25%
• Flexible Work Arrangements: Hybrid